Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 125 /hr

★★★★★

☆☆☆☆☆

Hire Mabel M.

Colombia

USD 125 /hr

Senior Market Access & Value Strategy Expert; HTA, Pricing & Innovative Access Models; LATAM & Emerging Markets

Profile Summary

I am a senior Market Access and Value Strategy expert with over 12 years of experience designing and executing end-to-end access, pricing, and HTA strategies in highly regulated healthcare systems across Latin America. I support pharmaceutical, biotech, consulting firms, and health organizations in solving complex access challenges—translating clinical and economic evidence into practical, executable strategies that secure reimbursement, improve payer alignment, and deliver commercial predictability. My expertise spans HTA and value dossiers, pricing governance and regulation, payer and government negotiations, innovative access and risk-sharing models, and market access operating models. I have led access strategies for oncology, rare diseases, diagnostics, cardiometabolic, and specialty portfolios, and I have worked both from the industry side (Roche, Sanofi, Novartis, Eli Lilly, Abbott) and the public sector (IETS, Ministry of Health), giving me a unique system-level perspective. On Kolabtree, I offer focused, outcome-oriented support, including: • Rapid review of market access and HTA strategies • Pricing and reimbursement strategy input • Advisory calls for payer engagement and negotiation preparation • Review and strengthening of value narratives and access dossiers • Executive-level guidance on access governance and decision frameworks Clients value my ability to quickly understand complex contexts, ask the right strategic questions, and deliver clear, actionable recommendations within short timelines. I am available for 1-hour advisory calls, short-term consulting engagements, and targeted strategic reviews. 1-hour strategic advisory call → USD 125 90-min deep-dive session → USD 155 Strategy review + written notes → Quotation

Subject Matter Expertise

• ★ Health Technology Assessment
• ★ Healthcare Reimbursement
• ★ Business Strategy
• ☆ In vitro Diagnostics
• ☆ Point-of-Care Devices
• ☆ Dermatology
• ☆ Oncology
• ☆ Chemotherapy
• ☆ Endocrinology
• ☆ Diabetes
• ☆ Cardiovascular Disease
• ☆ Cardiovascular Disease Management
• ☆ Healthcare Administration & Management
• ☆ Dermatitis
• ☆ Health Economics
• ☆ Economic Evaluation
• ☆ Innovation Management
• ☆ Corporate Governance

Services

• Writing

Writing Non-Medical Regulatory Writing, Technical Writing, Translation

Work Experience

Strategic Value and Access Lead

Eli Lilly

October 2024 - Present

International Procurement, Market Access and HEOR LATAM Head

Abbott Diagnostics

February 2023 - October 2024

Value-Based Healthcare Lead

Roche

November 2020 - September 2022

Education

Economics

Universidad Nacional de Colombia

July 2015 - September 2017

Master's Degree - Economics (Faculty of Economics)

Universidad Nacional de Colombia

- 2017

Postgraduate Degree - Statistics (Faculty of Sciences)

Universidad Nacional de Colombia

- 2010

Bachelor's Degree (Faculty of Economics)

Universidad Nacional de Colombia

- 2009

Certifications

• MBA Short-Term Program

  The London School of economics

  https://lse.credential.getsmarter.com/92d848ed-e72a-4dd2-abcb-fb8cf9c67cae#acc.gofp3ZPH

  January 2022 - Present